Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 4 boards, counting each seat separately. Longest: Design Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Design Therapeutics Inc. June 9, 202679.3%
-
CRISPR Therapeutics AG June 4, 202697.5%
-
CRISPR Therapeutics AG June 5, 202597.8%
-
Nkarta Inc. June 3, 202598.9%
-
CRISPR Therapeutics AG May 30, 202476.9%
-
CRISPR Therapeutics AG June 8, 202395.4%
-
Design Therapeutics Inc. May 31, 202396.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 14, 2026 | CRISPR Therapeutics AG | Option exercise | +30,000 | $14.00 | $420,000 |
| Oct 14, 2026 | CRISPR Therapeutics AG | Open-market sale | −14,514 | $49.63 | $720,373 |
| Sep 28, 2026 | ADARx Pharmaceuticals Inc. | Derivative conversion | +3,334,938 | — | — |
| Sep 28, 2026 | ADARx Pharmaceuticals Inc. | Derivative conversion | +1,113,666 | — | — |
| Sep 28, 2026 | ADARx Pharmaceuticals Inc. | Derivative conversion | +512,897 | — | — |
| Sep 28, 2026 | ADARx Pharmaceuticals Inc. | Open-market purchase | +592,593 | $17.00 | $10,074,081 |
| Sep 28, 2026 | ADARx Pharmaceuticals Inc. | Derivative conversion | +1,538,691 | — | — |
| Sep 28, 2026 | ADARx Pharmaceuticals Inc. | Open-market purchase | +414,814 | $17.00 | $7,051,838 |
| Sep 28, 2026 | ADARx Pharmaceuticals Inc. | Derivative conversion | +1,667,468 | — | — |
| Sep 28, 2026 | ADARx Pharmaceuticals Inc. | Derivative conversion | +169,001 | — | — |
| Sep 28, 2026 | ADARx Pharmaceuticals Inc. | Open-market purchase | +592,593 | $17.00 | $10,074,081 |
| May 11, 2026 | Odyssey Therapeutics Inc. | Derivative conversion | +474,048 | — | — |
| May 11, 2026 | Odyssey Therapeutics Inc. | Derivative conversion | +139,366 | — | — |
| May 11, 2026 | Odyssey Therapeutics Inc. | Derivative conversion | +59,692 | — | — |
| May 11, 2026 | Odyssey Therapeutics Inc. | Derivative conversion | +61,762 | — | — |
Questions about Simeon George
What boards is Simeon George on?
Simeon George sits on the boards of ADARx Pharmaceuticals Inc., CRISPR Therapeutics AG, Design Therapeutics Inc. and Nkarta Inc.
How long has Simeon George served on boards?
Our records show at least 10 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.